Letters

All Items

Letters may deliver information or news regarding an issue related to the Journal scope. If the letter relates to a published manuscript, the authors of the original manuscript will be given the opportunity to provide a response. Authors of Letters to the Editor should provide a short title. [800 words max]

  • Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial”

    Ottavia Borghese, Claudio Vincenzoni
    https://doi.org/10.4081/btvb.2024.141
    930
    PDF: 230

  • In memoriam of Professor Bruno Bizzi (1927-2023)

    Valerio De Stefano
    https://doi.org/10.4081/btvb.2023.110
    122
    PDF: 101

  • Palestinian patients associations appeal on World Hemophilia Day

    Sara Mellano
    https://doi.org/10.4081/btvb.2024.136
    275
    PDF: 73

  • ReDIP, the Italian network for the diagnosis of congenital platelet function disorders

    Marco Cattaneo, Claudia Ghali, Mariangela Scavone
    https://doi.org/10.4081/btvb.2024.134
    301
    PDF: 93

  • Synthetic platelets: can bioengineering realize in few years what evolution made in over 200 million years?

    Paolo Gresele
    https://doi.org/10.4081/btvb.2024.148
    1721
    PDF: 318

  • The diagnostic procedure for subjects with suspected pulmonary embolism. A recent comparison among the recommendations available from the international guidelines

    Gualtiero Palareti
    https://doi.org/10.4081/btvb.2024.122
    797
    PDF: 208
    Supplementary Material: 35

  • Thrombotic thrombocytopenic purpura: much done, but still a lot to do

    Paola Binetti
    https://doi.org/10.4081/btvb.2024.149
    448
    PDF: 145